[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595337":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":7,"responsibleParty":24,"collaborators":7,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":30,"acronym":31,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":7,"maxAge":7,"enrollmentInfo":34,"targetDuration":7,"studyType":37,"phases":7,"briefSummary":38,"conditions":39,"keywords":7,"overallStatus":41,"whyStopped":7,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":7},{"fullName":5,"class":6},"Getz Pharma","INDUSTRY",null,[9],{"name":10,"affiliation":11,"role":12},"Zulfiqarali G Abbas, MBBS, MMed, DTM&H","D-Foot International","PRINCIPAL_INVESTIGATOR",[14,20],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Muhammad Nabeed Tahir, MBBS","CONTACT","+9230153762","2907","nabeedtahir@getzpharma.com",{"name":21,"role":16,"phone":22,"phoneExt":7,"email":23},"Arsalan arif, MBBS","+923120279179","arsalan.arif@getzpharma.com",{"type":25,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100595337","diabetes-foot-africa-region-registry-100595337",false,"NCT07031141","Diabetes Foot Africa Region Registry","(D-FAR)","Inclusion Criteria:\n\n1. Male and female patients\n2. Residents of participating African countries.\n3. Diagnosed with diabetic foot complications (e.g., ulcers, gangrene, infection, ischemia).\n4. Patients with a history of foot ulcers or amputations due to diabetes.\n5. High-risk patients with peripheral neuropathy and\u002For peripheral arterial disease.\n\nExclusion Criteria:\n\n1. Non-diabetic foot complications.\n2. Acute traumatic injuries unrelated to diabetes.\n3. Patients unwilling to provide informed consent.","ALL",{"count":35,"type":36},2000,"ESTIMATED","OBSERVATIONAL","D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.",[40],"Diabetes","NOT_YET_RECRUITING","2025-06-12",{"date":44,"type":45},"2025-06-22","ACTUAL",{"date":47,"type":36},"2025-08-01",{"date":49,"type":36},"2027-02-01",{"name":5,"class":6}]